Effect of Cross Frequency tACS on Cognitive Control

Completed · Not applicable · Has a placebo group

Conditions studied: Cognitive Control, Executive Function

In brief

Investigation of frequency specific transcranial alternating current stimulation on cognitive control signals in frontal cortex

Key facts

Study ID

NCT03800030

Run by

University of North Carolina, Chapel Hill

People needed

26

Starts

2018-10-07

Expected to finish

2019-07-25

Last updated by the study team

2020-05-18

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Between the ages of 18 and 35 years
• Able to provide informed consent
• Willing to comply with all study procedures and be available for the duration of the study Speak and understand English

You may not qualify if…

• Attention Deficit Hyperactivity Disorder (currently under treatment)
• Neurological disorders and conditions, including, but not limited to:
• History of epilepsy
• Seizures (except childhood febrile seizures and electroconvulsive therapy induced seizures) Dementia
• History of stroke
• Parkinson's disease
• Multiple sclerosis
• Cerebral aneurysm
• Brain tumors
• Medical or neurological illness or treatment for a medical disorder that could interfere with study participation (e.g., unstable cardiac disease, malignancy)
• Prior brain surgery
• Any brain devices/implants, including cochlear implants and aneurysm clips
• History or current traumatic brain injury
• (For females) Pregnancy or breast feeding
• Personal or family history of mental/psychiatric disorder (e.g., anxiety, major depressive disorder, schizophrenia, etc.)
• Positive urine test for the following: Marijuana (THC), Cocaine (COC), Phencyclidine (PCP), Amphetamine (AMP), Ecstasy (MDMA), Methamphetamine (Mamp), Opiates (OPI), Oxycodone (OXY), Methadone (MTD), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Tricyclic Antidepressants (TCA), Propoxyphene (PPX)
• Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study

Where it is running

• University of North Carolina, Chapel Hill — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.